Cargando…
Gentamicin in Neonates with Hemodynamically Significant Patent Ductus Arteriosus
BACKGROUND: Gentamicin has been shown to cause vasodilation in preclinical studies. Hemodynamically significant patent ductus arteriosus (hsPDA) is a commonly observed congenital heart disorder in preterm neonates. Concomitant gentamicin theoretically shall delay the closure/result in nonclosure of...
Autores principales: | Sridharan, Kannan, Madhoob, Abdulraoof Al, Jufairi, Muna Al, Ansari, Eman Al, Marzooq, Reem Al, Hubail, Zakariya, Hasan, Sadiq Jaafar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353665/ https://www.ncbi.nlm.nih.gov/pubmed/37469643 http://dx.doi.org/10.4103/jpbs.jpbs_420_22 |
Ejemplares similares
-
Cumulative Doses Predict the Risk of Furosemide-Induced Electrolyte Abnormalities in Critically Ill Neonates
por: Sridharan, Kannan, et al.
Publicado: (2022) -
Is fat‐free mass‐based gentamicin dosing regimen preferable than whole‐body weight in neonates?
por: Sridharan, Kannan, et al.
Publicado: (2023) -
When to Treat Hemodynamically Insignificant Patent Ductus Arteriosus in Preterm Infants
por: Al-Abdi, Sameer Y.
Publicado: (2012) -
Evaluation of Genetic Polymorphisms of the Antioxidant Enzymes and Biomarkers of Oxidative Stress in Preterm Neonates With Respiratory Distress Syndrome Receiving External Surfactant
por: Sridharan, Kannan, et al.
Publicado: (2022) -
Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus
por: Al-lawama, Manar, et al.
Publicado: (2017)